Home

Jonathan Kennedy

CIK 1451629 · President and CEO · last filed 2021-05-04

Jonathan Kennedy is a President and CEO who has filed 56 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider was granted $10.6K of NTUS on May 4, 2021. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.62M

Companies

3

Total Filings

56

Lifetime Open-Market Net

-$6.89M

Filer Profile

Reported Address
INTERSIL CORPORATION
1001 MURPHY RANCH ROAD
MILPITAS, CA 95035
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NATUS MEDICAL INC (NTUS) Delisted President and CEO 191,810 $32.96 $6.32M -$505.6K 8 2021-05-04
IRMD Director 19,759 $82.22 $1.62M $0 9 2019-06-19
NATUS MEDICAL INC (BABY) Delisted President and CEO 139,517 — — -$6.38M 16 2019-01-24

Recent Filings

56 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-05-04 NATUS MEDICAL INC (NTUS) Delisted Grant (A) +489 $10.6K EDGAR
2021-04-16 NATUS MEDICAL INC (NTUS) Delisted Grant (A) — $0 EDGAR
2021-01-05 NATUS MEDICAL INC (NTUS) Delisted Mixed +29,036 $619.9K EDGAR
2020-11-03 NATUS MEDICAL INC (NTUS) Delisted Grant (A) +686 $10.6K EDGAR
2020-01-14 NATUS MEDICAL INC (NTUS) Delisted Grant (A) +42,101 $1.38M EDGAR
2020-01-06 NATUS MEDICAL INC (NTUS) Delisted Tax (F) −22,259 -$726.8K EDGAR
2019-12-09 NATUS MEDICAL INC (NTUS) Delisted Mixed +916 -$39.8K EDGAR
2019-11-06 NATUS MEDICAL INC (NTUS) Delisted Mixed +1,324 -$69.8K EDGAR
2019-06-19 IRMD Exer (M) +10,085 $0 EDGAR
2019-01-24 NATUS MEDICAL INC (BABY) Delisted Grant (A) +40,572 $1.37M EDGAR
Showing 1–10 of 56
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.